Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | CALL | $2.00 | 188 | +59 | +45.74% |
| 11/21/2025 | PUT | $1.50 | 60 | +9 | +17.65% |
| 08/15/2025 | CALL | $2.00 | 135 | +7 | +5.47% |
| 07/18/2025 | CALL | $1.00 | 2 | +1 | +100.00% |
| 07/18/2025 | CALL | $0.50 | 0 | 0 | |
| 07/18/2025 | CALL | $1.50 | 70 | 0 | |
| 11/21/2025 | PUT | $2.00 | 39 | -5 | -11.36% |
| 11/21/2025 | CALL | $2.50 | 6,528 | -7 | -0.11% |
| 11/21/2025 | CALL | $5.00 | 874 | -14 | -1.58% |
| 11/21/2025 | CALL | $2.00 | 321 | -16 | -4.75% |
| 11/21/2025 | CALL | $1.50 | 117 | -20 | -14.60% |
| 08/15/2025 | CALL | $5.00 | 1,387 | -25 | -1.77% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Alger Small Cap Focus Fund | 7.35% | 2.17M | 26.02M |
| Vanguard Total Stock Market Index Fund | 1.96% | 577.87k | 6.94M |
| Alger Fds II-Alger Dynamic Opportunities Fund | 1.47% | 434.01k | 5.21M |
| Vanguard Extended Market Index Fund | 0.95% | 280.64k | 3.37M |
| PGIM Jennison Health Sciences Fd | 0.87% | 257.29k | 3.09M |
| Fidelity Extended Market Index Fund | 0.40% | 117.05k | 1.41M |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.37% | 107.73k | 1.29M |
| Alger Fund-Small Cap Growth Fund | 0.34% | 100.54k | 1.21M |
| Dimensional ETF Tr-Dimensional U.S. Small Cap ETF | 0.23% | 67.11k | 805.99k |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.22% | 63.62k | 764.09k |
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
06/11 06:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in the Jefferies Global Healthcare Conference
05/29 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
01/29 09:00 am
GlobeNewswire Inc.
Read moreUS Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode
11/29 07:46 am
Benzinga
Read moreCabaletta Bio to Participate in Upcoming Investor Conferences in September
08/28 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
06/14 02:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
05/15 07:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
05/13 08:00 am
GlobeNewswire Inc.
Read moreWall Street Breakfast: The Week Ahead
05/05 06:27 am
Seeking Alpha
Read moreCabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
03/21 07:00 am
GlobeNewswire Inc.
Read moreCramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure'
03/06 10:20 am
Benzinga
Read moreCabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
02/01 05:30 pm
GlobeNewswire Inc.
Read moreVerint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
12/07 11:17 am
Benzinga
Read moreAnalyst Ratings for Cabaletta Bio
11/29 08:00 am
Benzinga
Read moreLeslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
11/29 06:48 am
Benzinga
Read moreCabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
11/28 06:04 pm
MarketWatch
Read moreCabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
11/28 05:30 pm
GlobeNewswire Inc.
Read moreCantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Know
11/15 01:00 pm
Benzinga
Read moreWhere Cabaletta Bio Stands With Analysts
11/10 11:00 am
Benzinga
Read moreCabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
11/09 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
10/30 08:00 am
GlobeNewswire Inc.
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
10/24 11:00 am
Benzinga
Read more7 Analysts Have This to Say About Cabaletta Bio
10/24 08:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
10/19 11:06 am
Benzinga
Read moreAre Medical Stocks Lagging Cabaletta Bio (CABA) This Year?
10/09 09:40 am
Zacks Investment Research
Read moreThe Latest Analyst Ratings for Cabaletta Bio
10/04 11:00 am
Benzinga
Read moreQIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
10/02 09:14 am
Zacks Investment Research
Read moreWhat Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing'
09/25 08:50 am
Zacks Investment Research
Read moreCabaletta Bio to Participate in Upcoming Investor Conferences in September
09/19 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio, Inc. (CABA) is on the Move, Here's Why the Trend Could be Sustainable
09/08 08:50 am
Zacks Investment Research
Read moreWhy America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
09/05 01:34 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
09/05 11:00 am
Benzinga
Read moreBrady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
09/05 10:43 am
Benzinga
Read moreAnalyst Ratings for Cabaletta Bio
09/05 08:00 am
Benzinga
Read moreWall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade
08/31 09:55 am
Zacks Investment Research
Read moreRecent Price Trend in Cabaletta Bio, Inc. (CABA) is Your Friend, Here's Why
08/23 08:50 am
Zacks Investment Research
Read moreDoes Cabaletta Bio, Inc. (CABA) Have the Potential to Rally 27.85% as Wall Street Analysts Expect?
08/15 01:46 pm
Zacks Investment Research
Read moreHC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
08/11 01:00 pm
Benzinga
Read moreCabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
07/24 08:00 am
GlobeNewswire Inc.
Read moreAnalyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
07/18 02:27 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
07/18 11:00 am
Benzinga
Read moreLa-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
06/21 06:39 am
Benzinga
Read moreCabaletta Bio Announces Pricing of Public Offering of Common Stock
05/17 10:16 pm
GlobeNewswire Inc.
Read moreCabaletta Bio Announces Proposed Public Offering of Common Stock
05/17 04:01 pm
GlobeNewswire Inc.
Read more